Professional Documents
Culture Documents
Process retains the amniotic growth factors
and cytokines inherent in this tissue. The
result is an injectable product that offers
surgeons a clear advantage.
Conta|ns a comb|nat|on ol rowtH
factors unique to placental tissue
beduces |nNammat|on at tHe |nject|on s|te
LnHances tHe norma| wound Hea||n
process
Product Offering
Safety
AmnioFix Injectable is processed using Purion,
a unique approach that provides an added level
of tissue safety and ease of use.
Lllect|ve m|crob|a| reduct|on, us|n
Purion System
1erm|na| ster|||zat|on us|n LBeam,
which does not harm AmnioFix Injectable
/mn|ol|x lnjectab|e |s never treated w|tH
|utara|deHyde or otHer cross||nk|n
agents, reducing concerns about potential
cytotoxicity
Ease of Use
AmnioFix Injectable has been specically
processed for optimum handling.
0ry powder preservat|on lor s|mp|e m|x|n
and application
byear sHe|l ||le at room temperature;
no special storage required
Soft Tissue Healing
In vivo and in vitro studies have shown that
the properties of amniotic membrane help
to reduce |nNammat|on and scar t|ssue
formation.
1,2,3,4
For use as an injection into
soft tissue, AmnioFix Injectable provides an
ellect|ve so|ut|on to reduce |nNammat|on and
support the natural healing process:
Inammation Reduction
Human amniotic tissue has been proven to
conta|n ant| |nNammatory prote|ns sucH as
|nter|euk|n |ll receptor antaon|st; t|ssue
|nH|b|tors ol meta||oprote|nase |1llls ,
Z, 3, 4; and llC
Non-immunogenic
Human amn|ot|c t|ssue |s non|mmunoen|c
and does not elicit a substantial immune
response
Ordering Information
Customer 3erv|ce: bb.4//.4Z9
Email: customerservice@mimedx.com
bC CHasta|n Center B|vd., 3u|te bC, bennesaw, 0/ 3C44 www.m|medx.com
AmnioFix